These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2850912)

  • 1. The new generation of antifungal drugs.
    Stevens DA
    Eur J Clin Microbiol Infect Dis; 1988 Dec; 7(6):732-5. PubMed ID: 2850912
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes.
    Back DJ; Tjia JF
    Br J Clin Pharmacol; 1991 Nov; 32(5):624-6. PubMed ID: 1659439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
    Gilgado F; Serena C; Cano J; Gené J; Guarro J
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4211-3. PubMed ID: 17015631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azoles, allylamines and drug metabolism.
    Back DJ; Tjia JF; Abel SM
    Br J Dermatol; 1992 Feb; 126 Suppl 39():14-8. PubMed ID: 1311943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of bifonazole, fluconazole, itraconazole, and terbinafine on the chemiluminescence response of immune cells.
    Abruzzo GK; Fromtling RA; Turnbull TA; Giltinan DM
    J Antimicrob Chemother; 1987 Jul; 20(1):61-8. PubMed ID: 3040658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species.
    Gupta AK; Kohli Y; Batra R
    Med Mycol; 2005 Mar; 43(2):179-85. PubMed ID: 15832561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azole antifungal agents: emphasis on new triazoles.
    Saag MS; Dismukes WE
    Antimicrob Agents Chemother; 1988 Jan; 32(1):1-8. PubMed ID: 2831809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility of Madurella mycetomatis to posaconazole and terbinafine.
    van Belkum A; Fahal AH; van de Sande WW
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1771-3. PubMed ID: 21263050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro response of cutaneous mycosis fungal agents to the most widely used systemic antifungals in dermatology.
    Almeida LM; Souza EA; Bianchin DB; Svidzinski TI
    An Bras Dermatol; 2009 Jul; 84(3):249-55. PubMed ID: 19668938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.
    Skóra M; Bulanda M; Jagielski T
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5827-9. PubMed ID: 26100698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal chemotherapy.
    Hoeprich PD
    Prog Drug Res; 1995; 44():87-127. PubMed ID: 7644668
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug-drug interaction of antifungal drugs].
    Niwa T; Shiraga T; Takagi A
    Yakugaku Zasshi; 2005 Oct; 125(10):795-805. PubMed ID: 16205037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of minimum inhibitory concentrations of itraconazole, terbinafine and ketoconazole against dermatophyte species by broth microdilution method.
    Bhatia VK; Sharma PC
    Indian J Med Microbiol; 2015; 33(4):533-7. PubMed ID: 26470960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing of organisms for susceptibility to triazoles: is it justified?
    Kobayashi GS; Spitzer ED
    Eur J Clin Microbiol Infect Dis; 1989 May; 8(5):387-9. PubMed ID: 2546774
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis.
    Cuenca-Estrella M; Gomez-Lopez A; Buitrago MJ; Mellado E; Garcia-Effron G; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2248-50. PubMed ID: 16723597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
    Bueno JG; Martinez C; Zapata B; Sanclemente G; Gallego M; Mesa AC
    Clin Exp Dermatol; 2010 Aug; 35(6):658-63. PubMed ID: 19874354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
    Gupta AK; Kohli Y
    Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antifungal activity of sertaconazole compared with nine other drugs against 250 clinical isolates of dermatophytes and Scopulariopsis brevicaulis.
    Carrillo-Muñoz AJ; Guglietta A; Palacín C; Casals J; del Valle O; Guardià C; Rodríguez V; Quindós G
    Chemotherapy; 2004 Dec; 50(6):308-13. PubMed ID: 15608448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New oral treatments for dermatophytosis.
    Hay RJ
    Ann N Y Acad Sci; 1988; 544():580-5. PubMed ID: 2850758
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro comparison of cilofungin alone and in combination with other antifungal agents against clinical isolates of Candida species.
    Smith KR; Lank KM; Dismukes WE; Cobbs CG
    Eur J Clin Microbiol Infect Dis; 1991 Jul; 10(7):588-92. PubMed ID: 1655435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.